Therapeutic insights and molecular mechanism linking melatonin signaling and membranous nephropathy (Review)
- Authors:
- Yen-Sung Huang
- Shuk-Man Ka
- Kuo-Cheng Lu
- Ann Chen
- Chia-Chao Wu
-
Affiliations: Institute of Biomedical Sciences, Academia Sinica, Taipei 115201, Taiwan, Graduate Institute of Aerospace and Undersea Medicine, National Defense Medical Center, Taipei 114201, Taiwan, Division of Nephrology, Department of Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei 231016, Taiwan, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 970473, Taiwan, Division of Nephrology, Department of Internal Medicine, Tri‑Service General Hospital, National Defense Medical Center, Taipei 114202, Taiwan - Published online on: June 12, 2025 https://doi.org/10.3892/br.2025.2017
- Article Number: 139
-
Copyright: © Huang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
 |
|
Tan DX, Zheng X, Kong J, Manchester LC, Hardeland R, Kim SJ, Xu X and Reiter RJ: Fundamental issues related to the origin of melatonin and melatonin isomers during evolution: Relation to their biological functions. Int J Mol Sci. 15:15858–15890. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Emet M, Ozcan H, Ozel L, Yayla M, Halici Z and Hacimuftuoglu A: A review of melatonin, its receptors and drugs. Eurasian J Med. 48:135–141. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Slominski AT, Zmijewski MA, Semak I, Kim TK, Janjetovic Z, Slominski RM and Zmijewski JW: Melatonin, mitochondria, and the skin. Cell Mol Life Sci. 74:3913–3925. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Liu J, Clough SJ, Hutchinson AJ, Adamah-Biassi EB, Popovska-Gorevski M and Dubocovich ML: MT1 and MT2 melatonin receptors: A therapeutic perspective. Annu Rev Pharmacol Toxicol. 56:361–383. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Reiter RJ, Mayo JC, Tan DX, Sainz RM, Alatorre-Jimenez M and Qin L: Melatonin as an antioxidant: Under promises but over delivers. J Pineal Res. 61:253–278. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Armstrong SM: Melatonin and circadian control in mammals. Experientia. 45:932–938. 1989.PubMed/NCBI View Article : Google Scholar | |
|
Hardeland R: Melatonin and inflammation-Story of a double-edged blade. J Pineal Res. 65(e12525)2018.PubMed/NCBI View Article : Google Scholar | |
|
Tordjman S, Chokron S, Delorme R, Charrier A, Bellissant E, Jaafari N and Fougerou C: Melatonin: Pharmacology, functions and therapeutic benefits. Curr Neuropharmacol. 15:434–443. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Xia Y, Chen S, Zeng S, Zhao Y, Zhu C, Deng B, Zhu G, Yin Y, Wang W, Hardeland R and Ren W: Melatonin in macrophage biology: Current understanding and future perspectives. J Pineal Res. 66(e12547)2019.PubMed/NCBI View Article : Google Scholar | |
|
Hardeland R: Aging, melatonin, and the Pro- and anti-inflammatory networks. Int J Mol Sci. 20(1223)2019.PubMed/NCBI View Article : Google Scholar | |
|
Kopustinskiene DM and Bernatoniene J: Molecular mechanisms of Melatonin-mediated cell protection and signaling in health and disease. Pharmaceutics. 13(129)2021.PubMed/NCBI View Article : Google Scholar | |
|
Nikolaev G, Robeva R and Konakchieva R: Membrane melatonin receptors activated cell signaling in physiology and disease. Int J Mol Sci. 23(471)2021.PubMed/NCBI View Article : Google Scholar | |
|
Tan DX, Reiter RJ, Manchester LC, Yan MT, El-Sawi M, Sainz RM, Mayo JC, Kohen R, Allegra M and Hardeland R: Chemical and physical properties and potential mechanisms: Melatonin as a broad spectrum antioxidant and free radical scavenger. Curr Top Med Chem. 2:181–197. 2002.PubMed/NCBI View Article : Google Scholar | |
|
Okamoto HH, Cecon E, Nureki O, Rivara S and Jockers R: Melatonin receptor structure and signaling. J Pineal Res. 76(e12952)2024.PubMed/NCBI View Article : Google Scholar | |
|
Klosen P: Thirty-seven years of MT1 and MT2 melatonin receptor localization in the brain: Past and future challenges. J Pineal Res. 76(e12955)2024.PubMed/NCBI View Article : Google Scholar | |
|
Afsar B, Elsurer Afsar R, Sag AA, Kanbay A, Korkmaz H, Cipolla-Neto J, Covic A, Ortiz A and Kanbay M: Sweet dreams: Therapeutic insights, targeting imaging and physiologic evidence linking sleep, melatonin and diabetic nephropathy. Clin Kidney J. 13:522–530. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Ekmekcioglu C: Melatonin receptors in humans: Biological role and clinical relevance. Biomed Pharmacother. 60:97–108. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Cagampang FR and Bruce KD: The role of the circadian clock system in nutrition and metabolism. Br J Nutr. 108:381–392. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Sanchez-Hidalgo M, de la Lastra CA, Carrascosa-Salmoral MP, Naranjo MC, Gomez-Corvera A, Caballero B and Guerrero JM: Age-related changes in melatonin synthesis in rat extrapineal tissues. Exp Gerontol. 44:328–334. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Thul PJ and Lindskog C: The human protein atlas: A spatial map of the human proteome. Protein Sci. 27:233–244. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Karlsson M, Zhang C, Mear L, Zhong W, Digre A, Katona B, Sjöstedt E, Butler L, Odeberg J, Dusart P, et al: A single-cell type transcriptomics map of human tissues. Sci Adv. 7(eabh2169)2021.PubMed/NCBI View Article : Google Scholar | |
|
Acuna-Castroviejo D, Rahim I, Acuna-Fernandez C, Fernández-Ortiz M, Solera-Marín J, Sayed RKA, Díaz-Casado ME, Rusanova I, López LC and Escames G: Melatonin, clock genes and mitochondria in sepsis. Cell Mol Life Sci. 74:3965–3987. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Konturek SJ, Konturek PC, Brzozowska I, Pawlik M, Sliwowski Z, Cześnikiewicz-Guzik M, Kwiecień S, Brzozowski T, Bubenik GA and Pawlik WW: Localization and biological activities of melatonin in intact and diseased gastrointestinal tract (GIT). J Physiol Pharmacol. 58:381–405. 2007.PubMed/NCBI | |
|
Fagerberg L, Hallstrom BM, Oksvold P, Kampf C, Djureinovic D, Odeberg J, Habuka M, Tahmasebpoor S, Danielsson A, Edlund K, et al: Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and Antibody-based proteomics. Mol Cell Proteomics. 13:397–406. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Huang YS, Lo CH, Tsai PH, Hou YC, Chang YT, Guo CY, Hsieh HY, Lu KC, Shih HM and Wu CC: Downregulation of AANAT by c-Fos in tubular epithelial cells with membranous nephropathy. Biochem Biophys Res Commun. 584:32–38. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Huang YS, Lu KC, Chao HW, Chen A, Chao TK, Guo CY, Hsieh HY, Shih HM, Sytwu HK and Wu CC: The MTNR1A mRNA is stabilized by the cytoplasmic hnRNPL in renal tubular cells. J Cell Physiol. 236:2023–2035. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Gazon H, Barbeau B, Mesnard JM and Peloponese JM Jr: Hijacking of the AP-1 Signaling pathway during development of ATL. Front Microbiol. 8(2686)2017.PubMed/NCBI View Article : Google Scholar | |
|
Hardeland R, Tan DX and Reiter RJ: Kynuramines, metabolites of melatonin and other indoles: The resurrection of an almost forgotten class of biogenic amines. J Pineal Res. 47:109–126. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Ma X, Idle JR, Krausz KW and Gonzalez FJ: Metabolism of melatonin by human cytochromes p450. Drug Metab Dispos. 33:489–494. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Tang KS, Ho CY, Hsu CN and Tain YL: Melatonin and Kidney Health: From Fetal Stage to Later Life. Int J Mol Sci. 24(8105)2023.PubMed/NCBI View Article : Google Scholar | |
|
Cecon E, Oishi A and Jockers R: Melatonin receptors: Molecular pharmacology and signalling in the context of system bias. Br J Pharmacol. 175:3263–3280. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Dubocovich ML, Delagrange P, Krause DN, Sugden D, Cardinali DP and Olcese J: International union of basic and clinical pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors. Pharmacol Rev. 62:343–380. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Liu L, Labani N, Cecon E and Jockers R: Melatonin target proteins: Too many or not enough? Front Endocrinol (Lausanne). 10(791)2019.PubMed/NCBI View Article : Google Scholar | |
|
Smirnov AN: Nuclear melatonin receptors. Biochemistry (Mosc). 66:19–26. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Slominski RM, Reiter RJ, Schlabritz-Loutsevitch N, Ostrom RS and Slominski AT: Melatonin membrane receptors in peripheral tissues: Distribution and functions. Mol Cell Endocrinol. 351:152–166. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Takahashi JS: Transcriptional architecture of the mammalian circadian clock. Nat Rev Genet. 18:164–179. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Jockers R, Delagrange P, Dubocovich ML, Markus RP, Renault N, Tosini G, Cecon E and Zlotos DP: Update on melatonin receptors: IUPHAR Review 20. Br J Pharmacol. 173:2702–2725. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Hardeland R, Cardinali DP, Srinivasan V, Spence DW, Brown GM and Pandi-Perumal SR: Melatonin-a pleiotropic, orchestrating regulator molecule. Prog Neurobiol. 93:350–384. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Reppert SM, Weaver DR and Godson C: Melatonin receptors step into the light: Cloning and classification of subtypes. Trends Pharmacol Sci. 17:100–102. 1996.PubMed/NCBI View Article : Google Scholar | |
|
Tao L and Zhu Y: Melatonin regulates CRE-dependent gene transcription underlying osteoblast proliferation by activating Src and PKA in parallel. Am J Transl Res. 10:86–100. 2018.PubMed/NCBI | |
|
Alexander SP, Davenport AP, Kelly E, Marrion N, Peters JA, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Southan C, et al: The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors. Br J Pharmacol. 172:5744–5869. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Brydon L, Roka F, Petit L, de Coppet P, Tissot M, Barrett P, Morgan PJ, Nanoff C, Strosberg AD and Jockers Rl: Dual signaling of human Mel1a melatonin receptors via G(i2), G(i3), and G(q/11) proteins. Mol Endocrinol. 13:2025–2038. 1999.PubMed/NCBI View Article : Google Scholar | |
|
Tosini G, Owino S, Guillaume JL and Jockers R: Understanding melatonin receptor pharmacology: Latest insights from mouse models, and their relevance to human disease. Bioessays. 36:778–787. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Tocharus C, Puriboriboon Y, Junmanee T, Tocharus J, Ekthuwapranee K and Govitrapong P: Melatonin enhances adult rat hippocampal progenitor cell proliferation via ERK signaling pathway through melatonin receptor. Neuroscience. 275:314–321. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Xia AY, Zhu H, Zhao ZJ, Liu HY, Wang PH, Ji LD and Xu J: Molecular mechanisms of the melatonin receptor pathway linking circadian rhythm to type 2 diabetes mellitus. Nutrients. 15(1406)2023.PubMed/NCBI View Article : Google Scholar | |
|
Li DY, Smith DG, Hardeland R, Yang MY, Xu HL, Zhang L, Yin HD and Zhu Q: Melatonin receptor genes in vertebrates. Int J Mol Sci. 14:11208–11223. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Reppert SM: Melatonin receptors: Molecular biology of a new family of G protein-coupled receptors. J Biol Rhythms. 12:528–531. 1997.PubMed/NCBI View Article : Google Scholar | |
|
Inoue T and Koike H: High-resolution low-temperature scanning electron microscopy for observing intracellular structures of quick frozen biological specimens. J Microsc. 156:137–147. 1989.PubMed/NCBI View Article : Google Scholar | |
|
Huang YS, Lu KC, Chao TK, Chen JS, Chen A, Guo CY, Hsieh HY, Shih HM, Sytwu HK and Wu CC: Role of melatonin receptor 1A and pituitary homeobox-1 coexpression in protecting tubular epithelial cells in membranous nephropathy. J Pineal Res. 65(e12482)2018.PubMed/NCBI View Article : Google Scholar | |
|
Couser WG: Primary membranous nephropathy. Clin J Am Soc Nephrol. 12:983–997. 2017.PubMed/NCBI View Article : Google Scholar | |
|
AlYousef A, AlSahow A, AlHelal B, Alqallaf A, Abdallah E, Abdellatif M, Nawar H and Elmahalawy R: Glomerulonephritis histopathological pattern change. BMC Nephrol. 21(186)2020.PubMed/NCBI View Article : Google Scholar | |
|
Hill SM, Cheng C, Yuan L, Mao L, Jockers R, Dauchy B, Frasch T and Blask DE: Declining melatonin levels and MT1 receptor expression in aging rats is associated with enhanced mammary tumor growth and decreased sensitivity to melatonin. Breast Cancer Res Treat. 127:91–98. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Adi N, Mash DC, Ali Y, Singer C, Shehadeh L and Papapetropoulos S: Melatonin MT1 and MT2 receptor expression in Parkinson's disease. Med Sci Monit. 16:BR61–ER67. 2010.PubMed/NCBI | |
|
Huang YS, Hsieh HY, Shih HM, Sytwu HK and Wu CC: Urinary Xist is a potential biomarker for membranous nephropathy. Biochem Biophys Res Commun. 452:415–421. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Wu CC, Lu KC, Lin YF, Chen JS, Huang CF, Chen CC, Lin SH, Chu P and Sytwu HK: Pathogenic role of effector cells and immunoglobulins in cationic bovine serum albumin-induced membranous nephropathy. J Clin Immunol. 32:138–149. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Wu CC, Lu KC, Lin GJ, Hsieh HY, Chu P, Lin SH and Sytwu HK: Melatonin enhances endogenous heme oxygenase-1 and represses immune responses to ameliorate experimental murine membranous nephropathy. J Pineal Res. 52:460–469. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Wu CC, Chen JS, Huang CF, Chen CC, Lu KC, Chu P, Sytwu HK and Lin YF: Approaching biomarkers of membranous nephropathy from a murine model to human disease. J Biomed Biotechnol. 2011(581928)2011.PubMed/NCBI View Article : Google Scholar | |
|
Wu CC, Chen JS, Lin SH, Chen A, Sytwu HK and Lin YF: Experimental model of membranous nephropathy in mice: Sequence of histological and biochemical events. Lab Anim. 42:350–359. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Wu CC, Chen JS, Chen SJ, Lin SH, Chen A, Chang LC, Sytwu HK and Lin YF: Kinetics of adaptive immunity to cationic bovine serum albumin-induced membranous nephropathy. Kidney Int. 72:831–840. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Koyanagi S, Hamdan AM, Horiguchi M, Kusunose N, Okamoto A, Matsunaga N and Ohdo S: cAMP-response element (CRE)-mediated transcription by activating transcription factor-4 (ATF4) is essential for circadian expression of the Period2 gene. J Biol Chem. 286:32416–32423. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Stuparevic I, Novacic A, Rahmouni AR, Fernandez A, Lamb N and Primig M: Regulation of the conserved 3'-5'exoribonuclease EXOSC10/Rrp6 during cell division, development and cancer. Biol Rev Camb Philos Soc. 96:1092–1113. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Schmid M and Jensen TH: The exosome: A multipurpose RNA-decay machine. Trends Biochem Sci. 33:501–510. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Johnston JD, Klosen P, Barrett P and Hazlerigg DG: Regulation of MT melatonin receptor expression in the foetal rat pituitary. J Neuroendocrinol. 18:50–56. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Johnston JD, Schuster C, Barrett P and Hazlerigg DG: Regulation of the ovine MT1 melatonin receptor promoter: Interaction between multiple pituitary transcription factors at different phases of development. Mol Cell Endocrinol. 268:59–66. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Kim M, de la Pena JB, Cheong JH and Kim HJ: Neurobiological functions of the period circadian clock 2 gene, Per2. Biomol Ther (Seoul). 26:358–367. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Huang YS, Lu KC, Chang YT, Ka SM, Guo CY, Hsieh HY, Shih HM, Sytwu HK and Wu CC: Melatonin alleviates Albumin-induced tubular cell injury by activating Clock-controlled nuclear enriched abundant transcript 1-mediated proliferation. ACS Pharmacol Transl Sci. 7:3607–3617. 2024.PubMed/NCBI View Article : Google Scholar | |
|
Alexopoulos E, Papagianni A and Papadimitriou M: Is membranous nephropathy only a glomerular disease? Ren Fail. 20:1–6. 1998.PubMed/NCBI View Article : Google Scholar | |
|
Remuzzi G, Ruggenenti P and Benigni A: Understanding the nature of renal disease progression. Kidney Int. 51:2–15. 1997.PubMed/NCBI View Article : Google Scholar | |
|
Albert FW and Kruglyak L: The role of regulatory variation in complex traits and disease. Nat Rev Genet. 16:197–212. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Daher G, Santos-Bezerra DP, Cavaleiro AM, Pelaes TS, Admoni SN, Perez RV, Machado CG, do Amaral FG, Cipolla-Neto J and Correa-Giannella ML: Rs4862705 in the melatonin receptor 1A gene is associated with renal function decline in type 1 diabetes individuals. Front Endocrinol (Lausanne). 15(1331012)2024.PubMed/NCBI View Article : Google Scholar | |
|
Loos F, Maduro C, Loda A, Lehmann J, Kremers GJ, Ten Berge D, Grootegoed JA and Gribnau J: Xist and tsix transcription dynamics is regulated by the X-to-autosome ratio and semistable transcriptional states. Mol Cell Biol. 36:2656–2667. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Lee JT, Davidow LS and Warshawsky D: Tsix, a gene antisense to Xist at the X-inactivation centre. Nat Genet. 21:400–404. 1999.PubMed/NCBI View Article : Google Scholar | |
|
Bisikirska B, Labella R, Cuesta-Dominguez A, Luo N, De Angelis J, Mosialou I, Lin CS, Beck D, Lata S, Shyu PT, et al: Melatonin receptor 1A variants as genetic cause of idiopathic osteoporosis. Sci Transl Med. 16(eadj0085)2024.PubMed/NCBI View Article : Google Scholar | |
|
Watt SM: The long and winding road: Homeostatic and disordered haematopoietic microenvironmental niches: A narrative review. Biomater Transl. 3:31–54. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Zhai H, Ni L and Wu X: The roles of heme oxygenase-1 in renal disease. Front Nephrol. 3(1156346)2023.PubMed/NCBI View Article : Google Scholar | |
|
Lee SC, Han SH, Li JJ, Lee SH, Jung DS, Kwak SJ, Kim SH, Kim DK, Yoo TH, Kim JH, et al: Induction of heme oxygenase-1 protects against podocyte apoptosis under diabetic conditions. Kidney Int. 76:838–848. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Li HB, Mo YS, Zhang XZ, Zhou Q, Liang XD, Song JN, Hou LN, Wu JN, Guo Y, Feng DD, et al: Heme oxygenase-1 inhibits renal tubular epithelial cell pyroptosis by regulating mitochondrial function through PINK1. Exp Ther Med. 25(213)2023.PubMed/NCBI View Article : Google Scholar | |
|
Rublevskaya I and Maines MD: Interaction of Fe-protoporphyrin IX and heme analogues with purified recombinant heme oxygenase-2, the constitutive isozyme of the brain and testes. J Biol Chem. 269:26390–26395. 1994.PubMed/NCBI | |
|
Stow LR and Gumz ML: The circadian clock in the kidney. J Am Soc Nephrol. 22:598–604. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Sasaki YT, Ideue T, Sano M, Mituyama T and Hirose T: MENepsilon/beta noncoding RNAs are essential for structural integrity of nuclear paraspeckles. Proc Natl Acad Sci USA. 106:2525–2530. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Sun X and Kaufman PD: Ki-67: More than a proliferation marker. Chromosoma. 127:175–186. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Rahman A, Hasan AU and Kobori H: Melatonin in chronic kidney disease: A promising chronotherapy targeting the intrarenal renin-angiotensin system. Hypertens Res. 42:920–923. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Koch BC, van der Putten K, Van Someren EJ, Wielders JP, Ter Wee PM, Nagtegaal JE and Gaillard CA: Impairment of endogenous melatonin rhythm is related to the degree of chronic kidney disease (CREAM study). Nephrol Dial Transplant. 25:513–519. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Ishigaki S, Ohashi N, Isobe S, Tsuji N, Iwakura T, Ono M, Sakao Y, Tsuji T, Kato A, Miyajima H and Yasuda H: Impaired endogenous nighttime melatonin secretion relates to intrarenal renin-angiotensin system activation and renal damage in patients with chronic kidney disease. Clin Exp Nephrol. 20:878–884. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Satari M, Bahmani F, Reiner Z, Soleimani A, Aghadavod E, Kheiripour N and Asemi Z: Metabolic and Anti-inflammatory response to melatonin administration in patients with diabetic nephropathy. Iran J Kidney Dis. 1:22–30. 2021.PubMed/NCBI | |
|
Hoxha E, Reinhard L and Stahl RAK: Membranous nephropathy: New pathogenic mechanisms and their clinical implications. Nat Rev Nephrol. 18:466–478. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Makhammajanov Z, Gaipov A, Myngbay A, Bukasov R, Aljofan M and Kanbay M: Tubular toxicity of proteinuria and the progression of chronic kidney disease. Nephrol Dial Transplant. 39:589–599. 2024.PubMed/NCBI View Article : Google Scholar | |
|
Hanset N, Esteve E, Plaisier E, Johanet C, Michel PA, Boffa JJ, Fievet P, Mesnard L, Morelle J, Ronco P and Dahan K: Rituximab in patients with phospholipase A2 Receptor-associated membranous nephropathy and severe CKD. Kidney Int Rep. 5:331–338. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Trujillo H, Alonso M and Praga M: New ways of understanding membranous nephropathy. Nephron. 144:261–271. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Rojas-Rivera JE, Ortiz A and Fervenza FC: Novel treatments paradigms: Membranous nephropathy. Kidney Int Rep. 8:419–431. 2023.PubMed/NCBI View Article : Google Scholar |
